Table 3.
Association of the Polymorphisms in CETP gene with TG, TC, LDL-C and HDL-C in two groups.
| SNP | Group | Genotypes | n | TG | TC | LDL-C | HDL-C |
|---|---|---|---|---|---|---|---|
| rs708272 | Normal Control | CC | 209 | 0.83 ± 0.31 * | 4.04 ± 0.77 | 2.08 ± 0.55 * | 1.45 ± 0.31 |
| CT | 362 | 0.77 ± 0.27 * | 3.99 ± 0.65 | 2.00 ± 0.51 | 1.43 ± 0.28 * | ||
| TT | 186 | 0.80 ± 0.28 | 3.96 ± 0.74 | 1.96 ± 0.52 * | 1.51 ± 0.30 * | ||
| Dyslipidemia | CC | 231 | 2.24 ± 2.42 | 4.89 ± 1.63 | 2.74 ± 1.09 | 1.07 ± 0.46 | |
| CT | 322 | 2.07 ± 1.15 | 4.78 ± 1.54 * | 2.65 ± 1.02 * | 1.07 ± 0.40 | ||
| TT | 156 | 2.25 ± 1.57 | 5.15 ± 1.57 * | 2.88 ± 1.12 * | 1.14 ± 0.43 | ||
| rs1800775 | Normal Control | AA | 281 | 0.83 ± 0.27 * | 4.01 ± 0.65 | 1.99 ± 0.52 | 1.48 ± 0.30 |
| AC | 343 | 0.77 ± 0.28 * | 3.99 ± 0.67 | 2.02 ± 0.52 | 1.44 ± 0.30 | ||
| CC | 132 | 0.80 ± 0.31 | 3.96 ± 0.90 | 2.04 ± 0.56 | 1.45 ± 0.26 | ||
| Dyslipidemia | AA | 236 | 2.15 ± 1.42 | 5.02 ± 1.59 | 2.80 ± 1.09 | 1.12 ± 0.42 | |
| AC | 318 | 2.22 ± 1.95 | 4.88 ± 1.57 | 2.73 ± 1.08 | 1.06 ± 0.38 | ||
| CC | 152 | 2.08 ± 1.77 | 4.77 ± 1.57 | 2.63 ± 1.01 | 1.08 ± 0.52 | ||
| rs3764261 | Normal Control | GG | 351 | 0.81 ± 0.29 | 4.00 ± 0.73 | 2.05 ± 0.53 | 1.44 ± 0.29 |
| GT | 334 | 0.78 ± 0.27 | 3.99 ± 0.67 | 1.98 ± 0.53 | 1.47 ± 0.31 | ||
| TT | 72 | 0.83 ± 0.30 | 4.03 ± 0.76 | 2.02 ± 0.49 | 1.46 ± 0.24 | ||
| Dyslipidemia | GG | 394 | 2.15 ± 1.97 | 4.82 ± 1.59 * | 2.68 ± 1.05 | 1.08 ± 0.44 | |
| GT | 264 | 2.22 ± 1.47 | 4.93 ± 1.59 | 2.75 ± 1.04 | 1.10 ± 0.42 | ||
| TT | 51 | 2.04 ± 1.08 | 5.31 ± 1.41 * | 2.99 ± 1.26 | 1.10 ± 0.35 | ||
| rs711752 | Normal Control | GG | 209 | 0.83 ± 0.31 * | 4.04 ± 0.77 | 2.08 ± 0.55 * | 1.45 ± 0.31 |
| AG | 362 | 0.77 ± 0.27 * | 3.99 ± 0.65 | 2.00 ± 0.51 | 1.43 ± 0.28 * | ||
| AA | 186 | 0.80 ± 0.28 | 3.96 ± 0.74 | 1.96 ± 0.52 * | 1.51 ± 0.30 * | ||
| Dyslipidemia | GG | 230 | 2.24 ± 2.42 | 4.89 ± 1.63 | 2.74 ± 1.09 | 1.07 ± 0.46 | |
| AG | 323 | 2.07 ± 1.15 | 4.78 ± 1.54 * | 2.65 ± 1.02 * | 1.07 ± 0.40 | ||
| AA | 156 | 2.25 ± 1.57 | 5.15 ± 1.57 * | 2.88 ± 1.12 * | 1.14 ± 0.43 | ||
| rs12149545 | Normal Control | GG | 360 | 0.81 ± 0.29 | 4.00 ± 0.73 | 2.05 ± 0.53 | 1.44 ± 0.29 |
| AG | 329 | 0.78 ± 0.27 | 3.99 ± 0.67 | 1.98 ± 0.53 | 1.47 ± 0.31 | ||
| AA | 68 | 0.83 ± 0.30 | 4.02 ± 0.77 | 2.01 ± 0.48 | 1.46 ± 0.24 | ||
| Dyslipidemia | GG | 408 | 2.18 ± 1.96 | 4.84 ± 1.57 * | 2.69 ± 1.05 * | 1.07 ± 0.44 | |
| AG | 251 | 2.17 ± 1.47 | 4.91 ± 1.62 | 2.74 ± 1.05 | 1.10 ± 0.42 | ||
| AA | 50 | 2.05 ± 1.09 | 5.33 ± 1.41 * | 3.01 ± 1.26 * | 1.10 ± 0.36 |
*, p < 0.05.